GLP-1 Maintenance Dose vs Stopping Completely: What the Evidence Says

If your weight has stabilized on a GLP-1, you are probably weighing one big question: do you stay on a maintenance dose, step down to something lower, or stop completely? The honest answer is that these are not two choices but a spectrum, and every point on it is a decision you make together with your prescriber, not on your own. Here is what the evidence actually says about each path so you can walk into that conversation informed.

The spectrum of options

People tend to picture a binary: "on the drug" or "off the drug." In practice, clinicians work along a range of approaches, and where you land depends on your history, your regain risk, cost, side effects, and your goals. The obesity medicine literature increasingly frames long-term GLP-1 use as chronic disease management rather than a short course you finish, which is why so many of these paths keep some medication in the picture. You can read more about how the different discontinuation routes compare in our tapering guide.

• Staying on your full dose: continuing the dose that got you to a stable weight, on the logic that obesity is a chronic, relapsing condition and treatment often needs to continue for the benefit to continue.
• A clinician-guided lower or maintenance dose: stepping down to a smaller ongoing dose that still provides appetite regulation with fewer side effects or lower cost.
• Reduced-frequency dosing: keeping your dose but spacing injections further apart under medical supervision.
• A guided taper: gradually stepping down over weeks or months with a plan to stop, giving your body time to adjust.
• Stopping completely: discontinuing the medication, ideally with a maintenance plan in place first. See our maintenance guide for what that plan looks like.

What the evidence shows on reduced-frequency dosing

One of the more encouraging findings for people who want to use less medication is around reduced-frequency dosing, spacing out injections rather than lowering the amount. Under medical supervision, this approach has been associated with preserving roughly 70% of the weight lost. That is a meaningful signal: it suggests some people may be able to hold most of their results on less frequent dosing, though results vary from person to person and this is not a strategy to improvise at home.

What about microdosing?

"Microdosing," meaning using amounts below the approved therapeutic doses, has become a popular online talking point. It is important to be clear: microdosing below approved doses is not recommended and is not evidence-based. The doses studied and approved are the ones with data behind them. Going below that range, especially with compounded or non-standard products, moves you into territory where nobody can tell you what to expect.

Why abrupt stopping tends to backfire

Of all the paths, stopping cold tends to produce the sharpest rebound in hunger and weight. When the medication clears, the appetite signals it was quieting can come back quickly, and the body's drive to regain lost weight reasserts itself. This is physiology, not a failure of willpower: obesity behaves like a chronic condition, and removing treatment can let the condition recur. That is exactly why a planned, gradual approach is usually gentler than an abrupt one. Our piece on why weight comes back after GLP-1 unpacks the biology, and if a step-down is on the table, the taper calculator can help you and your clinician visualize a schedule to discuss.

Questions to bring to your clinician

You do not have to arrive with a decision already made. You just need good questions. Bring these to your next visit, and if a taper is what you land on, our walkthrough on how to taper off GLP-1 covers what a supervised step-down can look like.

• Given my regain risk and health history, would you lean toward a maintenance dose, a step-down, or stopping?
• Is reduced-frequency dosing a reasonable option for me, and how would we monitor it?
• If we lower the dose, what should I watch for in the weeks after the change?
• What is your plan if hunger or weight starts to climb again?
• How do cost and insurance coverage factor into which path makes sense for me?

The bottom line

Maintenance dose versus stopping completely is not a coin flip. It is a spectrum that runs from full-dose continuation, through lower or maintenance doses and supervised reduced-frequency dosing, to a guided taper or a full stop. Reduced-frequency dosing under medical care has held onto most of the weight loss for many people, abrupt stopping tends to trigger the sharpest rebound, and microdosing below approved doses is not a shortcut worth taking. The right path is the one you and your clinician choose together, backed by a real maintenance plan for whatever comes next.